CY1106912T1 - Υδροξυ-υποκατεστημενες 2-αζετιδινονες χρησιμες σαν υποχοληστερολαιμικοι παραγοντες - Google Patents

Υδροξυ-υποκατεστημενες 2-αζετιδινονες χρησιμες σαν υποχοληστερολαιμικοι παραγοντες

Info

Publication number
CY1106912T1
CY1106912T1 CY20071101279T CY071101279T CY1106912T1 CY 1106912 T1 CY1106912 T1 CY 1106912T1 CY 20071101279 T CY20071101279 T CY 20071101279T CY 071101279 T CY071101279 T CY 071101279T CY 1106912 T1 CY1106912 T1 CY 1106912T1
Authority
CY
Cyprus
Prior art keywords
substituted
subacute
hydroxy
steroidal agents
cholesterol
Prior art date
Application number
CY20071101279T
Other languages
English (en)
Inventor
Anima Ghosal
Shmuel Zbaida
Swapan K Chowdhury
Robert M Iannucci
Wenqing Feng
Kevin B Alton
James E Patrick
Harry R Davis
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22973953&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106912(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP05004699A external-priority patent/EP1593670B1/en
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of CY1106912T1 publication Critical patent/CY1106912T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Υποχοληστερολαιμικές ενώσεις σάκχαρο-υποκατεστημένης 2-αζετιδινόνης του τύπου: αποκαλύπτονται, καθώς επίσης μέθοδος μείωσης της χοληστερόλης με χορήγηση των αναφερθεισών ενώσεων, φαρμακευτικές συνθέσεις που τις περιέχουν και ο συνδυασμός ενός παράγοντα μείωσης της χοληστερόλης σάκχαρο-υποκατεστημένης 2-αζετιδινόνης και ενός αναστολέα βιοσύνθεσης χοληστερόλης για τη θεραπεία και πρόληψη αθηροσκλήρωσης.
CY20071101279T 2000-12-20 2007-10-08 Υδροξυ-υποκατεστημενες 2-αζετιδινονες χρησιμες σαν υποχοληστερολαιμικοι παραγοντες CY1106912T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25687500P 2000-12-20 2000-12-20
EP05004699A EP1593670B1 (en) 2000-12-20 2001-12-17 Hydroxy-substituted 2-azetidinones useful as hypocholesterolemic agents

Publications (1)

Publication Number Publication Date
CY1106912T1 true CY1106912T1 (el) 2012-09-26

Family

ID=22973953

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101279T CY1106912T1 (el) 2000-12-20 2007-10-08 Υδροξυ-υποκατεστημενες 2-αζετιδινονες χρησιμες σαν υποχοληστερολαιμικοι παραγοντες

Country Status (35)

Country Link
US (1) US20020137690A1 (el)
EP (1) EP1347987B1 (el)
JP (2) JP4351842B2 (el)
KR (1) KR100883461B1 (el)
CN (1) CN100475829C (el)
AR (1) AR035611A1 (el)
AT (2) ATE279425T1 (el)
AU (2) AU2002231049B2 (el)
BR (1) BR0116212A (el)
CA (1) CA2432798C (el)
CY (1) CY1106912T1 (el)
CZ (1) CZ302193B6 (el)
DE (2) DE60129863T2 (el)
DK (2) DK1347987T3 (el)
EC (1) ECSP034659A (el)
ES (2) ES2287826T3 (el)
GE (1) GEP20053548B (el)
HK (2) HK1056735A1 (el)
HU (1) HUP0302269A3 (el)
IL (1) IL155771A0 (el)
MA (1) MA26975A1 (el)
MX (1) MXPA03005671A (el)
MY (1) MY129148A (el)
NO (2) NO326981B1 (el)
NZ (1) NZ525722A (el)
PE (1) PE20020718A1 (el)
PL (1) PL208242B1 (el)
PT (2) PT1593670E (el)
RU (1) RU2297422C2 (el)
SI (2) SI1593670T1 (el)
SK (1) SK286703B6 (el)
TR (1) TR200402758T4 (el)
TW (1) TWI316942B (el)
WO (1) WO2002050090A1 (el)
ZA (1) ZA200303694B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ527852A (en) 2001-03-28 2005-03-24 Schering Corp Enantioselective synthesis of azetidinone intermediate compounds
GB0215579D0 (en) * 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
JP2005015434A (ja) * 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (en) * 2003-10-07 2005-04-13 Lipideon Biotechnology AG Novel hypocholesterolemic compounds
EP1918000A2 (en) 2003-11-05 2008-05-07 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
CA2550215A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
CA2550373C (en) 2003-12-23 2012-01-31 Merck & Co., Inc. Anti-hypercholesterolemic compounds
GB0329778D0 (en) * 2003-12-23 2004-01-28 Astrazeneca Ab Chemical compounds
JP2008514718A (ja) * 2004-09-29 2008-05-08 シェーリング コーポレイション 置換アゼチドノンおよびｃｂ１アンタゴニストの組み合わせ
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
SA06270191B1 (ar) * 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AR054482A1 (es) * 2005-06-22 2007-06-27 Astrazeneca Ab Derivados de azetidinona para el tratamiento de hiperlipidemias
CN101394837A (zh) * 2006-03-06 2009-03-25 特瓦制药工业有限公司 折替米贝组合物
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
WO2008122014A1 (en) * 2007-04-02 2008-10-09 Theracos, Inc. Benzylic glycoside derivatives and methods of use
US20110243940A1 (en) 2008-12-16 2011-10-06 Schering Corporation Bicyclic pyranone derivatives and methods of use thereof
EP2379547A1 (en) 2008-12-16 2011-10-26 Schering Corporation Pyridopyrimidine derivatives and methods of use thereof
KR20110120320A (ko) * 2009-02-11 2011-11-03 다우 아그로사이언시즈 엘엘씨 살충 조성물
EP2403848A1 (en) 2009-03-06 2012-01-11 Lipideon Biotechnology AG Pharmaceutical hypocholesterolemic compositions
WO2010113175A2 (en) 2009-04-01 2010-10-07 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
KR101102749B1 (ko) * 2009-11-30 2012-01-05 최길용 곱셈 학습기
KR20150079373A (ko) 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
CN105055404B (zh) * 2015-08-19 2017-07-18 四川大学 Hmgcs2抑制剂在制备治疗***成瘾的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5627176A (en) * 1994-03-25 1997-05-06 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
ES2175141T3 (es) * 1995-10-31 2002-11-16 Schering Corp 2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicos.
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
AUPQ342599A0 (en) * 1999-10-14 1999-11-04 University Of Melbourne, The Conjugates and uses thereof

Also Published As

Publication number Publication date
WO2002050090A8 (en) 2004-04-15
RU2003122520A (ru) 2005-02-27
HUP0302269A2 (hu) 2003-10-28
BR0116212A (pt) 2003-12-30
GEP20053548B (en) 2005-06-27
HK1084945A1 (en) 2006-08-11
CA2432798C (en) 2007-02-27
ZA200303694B (en) 2004-08-13
MA26975A1 (fr) 2004-12-20
ATE279425T1 (de) 2004-10-15
EP1347987B1 (en) 2004-10-13
NO20032806L (no) 2003-08-19
DK1593670T3 (da) 2007-11-05
KR100883461B1 (ko) 2009-02-16
ES2230385T3 (es) 2005-05-01
HK1056735A1 (en) 2004-02-27
AR035611A1 (es) 2004-06-16
RU2297422C2 (ru) 2007-04-20
TWI316942B (en) 2009-11-11
CA2432798A1 (en) 2002-06-27
SK7702003A3 (en) 2003-10-07
TR200402758T4 (tr) 2004-11-22
AU2002231049B2 (en) 2006-07-20
CN1483039A (zh) 2004-03-17
PE20020718A1 (es) 2002-08-09
DE60106489T2 (de) 2005-10-13
EP1347987A1 (en) 2003-10-01
PL208242B1 (pl) 2011-04-29
PL363237A1 (en) 2004-11-15
PT1593670E (pt) 2007-11-08
DE60129863T2 (de) 2008-04-30
US20020137690A1 (en) 2002-09-26
DE60106489D1 (de) 2004-11-18
JP4351842B2 (ja) 2009-10-28
AU3104902A (en) 2002-07-01
JP2009132745A (ja) 2009-06-18
IL155771A0 (en) 2003-12-23
NZ525722A (en) 2004-11-26
DK1347987T3 (da) 2005-01-31
CN100475829C (zh) 2009-04-08
ES2287826T3 (es) 2007-12-16
MY129148A (en) 2007-03-30
NO20083737L (no) 2003-08-19
SK286703B6 (sk) 2009-03-05
WO2002050090A1 (en) 2002-06-27
ATE369334T1 (de) 2007-08-15
NO20032806D0 (no) 2003-06-19
DE60129863D1 (de) 2007-09-20
CZ20031674A3 (cs) 2003-10-15
KR20030063414A (ko) 2003-07-28
CZ302193B6 (cs) 2010-12-08
MXPA03005671A (es) 2003-10-06
ECSP034659A (es) 2003-07-25
PT1347987E (pt) 2005-01-31
SI1347987T1 (en) 2005-02-28
NO326981B1 (no) 2009-03-30
SI1593670T1 (sl) 2007-12-31
JP2004516299A (ja) 2004-06-03
HUP0302269A3 (en) 2009-08-28

Similar Documents

Publication Publication Date Title
CY1106912T1 (el) Υδροξυ-υποκατεστημενες 2-αζετιδινονες χρησιμες σαν υποχοληστερολαιμικοι παραγοντες
MY114803A (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
NZ514409A (en) C7 ester substituted taxanes as antitumor agents
NO20020214L (no) Substituerte oksoazaheterocyklylforbindelser
DE69830504D1 (de) Antithrombotische mitteln
CY1108714T1 (el) Ανταγωνιστες υποδοχεα cgrp
EA200300970A1 (ru) Энантиоселективный синтез промежуточных соединений для получения азетидинонов
CY1111440T1 (el) 5-χλωρο-3-(4-μεθανοσουλφονυλφαινυλ)-6'-μεθυλ-[2,3']διπυριδινυλ σε καθαρη κρυσταλλικη μορφη και διαδικασια για συνθεση
CY1109240T1 (el) Συνδυασμος που περιλαμβανει βαλσαρτανη, αμλοδιπινη και υδροχλωροθειαζιδιο
ATE283253T1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
BR0213063A (pt) Antibióticos de ação dupla
ATE489093T1 (de) Heilmittel für hyperlipidämie
ATE413388T1 (de) Muskarin antagonisten
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
RS108504A (en) Ring-substituted diphenyl azetidinones, method for the production thereof,medicaments containing said compounds, and use thereof
BR0104350A (pt) Taxanos de c10 acetato heterossubstituìdo como agentes antitumor
JO2409B1 (en) Second-phenyl carboxy amides are useful as lipid-lowering agents
MY129310A (en) C-4 carbonate taxanes
ATE498600T1 (de) Inden derivate als pharmazeutika
ATE405568T1 (de) Cytotoxische mittel
BR0105563A (pt) Derivados e análogos de galantamina
ATE453389T1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
ATE308540T1 (de) Antithrombosemittel
WO2002028880A8 (en) Compounds useful for treating hypertriglyceridemia
DE60142308D1 (de) Vorbeugungs- oder heilmittel gegen endometriose